Brain Research · 2017 · 34 citations · 37 references
MedicineNeurosciencePharmacologyDementiaNeurodegenerationNeuropharmacologyAlzheimer DiseaseDementia TreatmentNeurodegenerative Disease PharmacotherapyNeurodegenerative DiseasesNeurodegenerative DisordersNeuropathology Of DementiaAlzheimer Disease NeuroprotectionAlzheimer Disease ProgressionAlzheimer's Disease ModelsAmyloid Beta PathwaysAmyloid Beta-targeted TherapyAmyloid Pathology ModelsTherapeutic Targeting Of Amyloid
37
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 2K citations · Full text
Medicine, Neurology, Pharmacology +17
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text
Medicine, Neurology, Neuroscience +14
Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits
Kullervo Hynynen, Nathan McDannold, Natalia Vykhodtseva et al. · Radiology · 2001 · 1.5K citations
Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
Mahiuddin Ahmed, Judianne Davis, Darryl Aucoin et al. · Nature Structural & Molecular Biology · 2010 · 1.1K citations · Full text